Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,407 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world first-line treatment with pembrolizumab for non-small cell lung carcinoma with high PD-L1 expression: Updated analysis.
Ikezawa Y, Morita R, Mizugaki H, Tateishi K, Yokoo K, Sumi T, Kikuchi H, Kitamura Y, Nakamura A, Kobayashi M, Aso M, Kimura N, Yoshiike F, Megumi F, Tanaka H, Sekikawa M, Hachiya T, Nakamura K, Hommura F, Sukoh N, Ito K, Kikuchi T, Agatsuma T, Yokouchi H. Ikezawa Y, et al. Among authors: kitamura y. Cancer Med. 2024 Jul;13(14):e70036. doi: 10.1002/cam4.70036. Cancer Med. 2024. PMID: 39030894 Free PMC article.
Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression.
Ikezawa Y, Mizugaki H, Morita R, Tateishi K, Yokoo K, Sumi T, Kikuchi H, Kitamura Y, Nakamura A, Kobayashi M, Aso M, Kimura N, Yoshiike F, Furuta M, Tanaka H, Sekikawa M, Hachiya T, Nakamura K, Shimokawa M, Oizumi S. Ikezawa Y, et al. Among authors: kitamura y. Cancer Sci. 2022 Jun;113(6):2109-2117. doi: 10.1111/cas.15361. Epub 2022 Apr 15. Cancer Sci. 2022. PMID: 35377496 Free PMC article.
Durvalumab after chemoradiotherapy in non-small cell lung cancer with EGFR mutation: A real-world study (HOT2101).
Tsuji K, Mizugaki H, Yokoo K, Kobayashi M, Kawashima Y, Kimura N, Yokouchi H, Kikuchi H, Sumi T, Kawai Y, Kobashi K, Morita R, Ito K, Kitamura Y, Minemura H, Nakamura K, Aso M, Honjo O, Tanaka H, Takashina T, Tsurumi K, Sugisaka J, Tsukita Y, Konno S, Oizumi S. Tsuji K, et al. Among authors: kitamura y. Cancer Sci. 2024 Apr;115(4):1273-1282. doi: 10.1111/cas.16094. Epub 2024 Jan 29. Cancer Sci. 2024. PMID: 38287788 Free PMC article.
Ramucirumab-induced Multiple Haemangiomas of the Skin: Two Case Reports.
Kosumi H, Nishie W, Sugai T, Toyonaga E, Yoshimoto N, Nakamura H, Horibe R, Kitamura Y, Nakatsumi H, Shimizu H. Kosumi H, et al. Among authors: kitamura y. Acta Derm Venereol. 2018 Apr 16;98(4):454-455. doi: 10.2340/00015555-2869. Acta Derm Venereol. 2018. PMID: 29327066 Free article. No abstract available.
Increased microcirculation in subepithelial invasion of lung cancer.
Yamada G, Kitamura Y, Kitada J, Yamada Y, Takahashi M, Fujii M, Takahashi H. Yamada G, et al. Among authors: kitamura y. Intern Med. 2011;50(8):839-43. doi: 10.2169/internalmedicine.50.4465. Epub 2011 Apr 15. Intern Med. 2011. PMID: 21498931 Free article.
Pseudo-outbreak of Mycobacterium lentiflavum at a general hospital in Japan.
Nagano Y, Kuronuma K, Kitamura Y, Nagano K, Yabe H, Kudo S, Sato T, Nirasawa S, Nakae M, Horiuchi M, Yokota SI, Fujiya Y, Saito A, Takahashi S, Chiba H. Nagano Y, et al. Among authors: kitamura y. Infect Control Hosp Epidemiol. 2023 Nov;44(11):1809-1815. doi: 10.1017/ice.2023.68. Epub 2023 Apr 25. Infect Control Hosp Epidemiol. 2023. PMID: 37096433 Free PMC article.
Bronchoscopic observation of endobronchial tumor cells.
Kitamura Y, Yamada G, Narita Y, Kameda M, Yamada Y, Kitada J, Ikeda K, Takahashi H. Kitamura Y, et al. J Bronchology Interv Pulmonol. 2012 Oct;19(4):311-2. doi: 10.1097/LBR.0b013e31826b36a8. J Bronchology Interv Pulmonol. 2012. PMID: 23207531
2,407 results